(Total Views: 177)
Posted On: 10/07/2019 8:55:44 AM
Post# of 103733
$SMMT News Article - Summit Therapeutics Reports New Data from Phase 2 Clinical Trial Connecting Ridinilazole's Microbiome Preservation to Improved Clinical Outcomes for Patients with C. difficile Infection https://marketwirenews.com/news-releases/summ...15099.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
